Ironwood Pharmaceuticals, Inc. (IRWD) Earnings History
Annual and quarterly earnings data from 2007 to 2025
Loading earnings history...
IRWD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IRWD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 99.4% | 40.1% | 8.1% |
| 2024 | 97.9% | 26.5% | 0.3% |
| 2023 | 98.6% | -213.5% | -226.4% |
| 2022 | 99.7% | 61.0% | 42.6% |
| 2021 | 83.0% | 56.1% | 127.7% |
Download Data
Export IRWD earnings history in CSV or JSON format
Free sign-in required to download data
Ironwood Pharmaceuticals, Inc. (IRWD) Earnings Overview
As of May 8, 2026, Ironwood Pharmaceuticals, Inc. (IRWD) reported trailing twelve-month net income of $151M. The company earned $0.91 per diluted share over the past four quarters, with a net profit margin of 8.1%.
Looking at the long-term picture, IRWD's 5-year EPS compound annual growth rate (CAGR) stands at -25.6%, signaling declining earnings. The company achieved its highest annual net income of $528M in fiscal 2021.
Ironwood Pharmaceuticals, Inc. maintains positive profitability with a gross margin of 99.4%, operating margin of 40.1%, and net margin of 8.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PTGX (-$115M net income, -282.8% margin), ARDX (-$58M net income, -15.1% margin), CPIX (-$7M net income, -6.4% margin), IRWD has outperformed on profitability metrics. Compare IRWD vs PTGX →
IRWD Earnings vs Peers
Earnings metrics vs comparable public companies
IRWD Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $24M | +2629.2% | $119M | $0.15 | 8.1% | 40.1% |
| 2024 | $880,000 | +100.1% | $93M | $0.01 | 0.3% | 26.5% |
| 2023 | -$1.00B | -672.5% | -$945M | $-6.45 | -226.4% | -213.5% |
| 2022 | $175M | -66.9% | $250M | $0.96 | 42.6% | 61.0% |
| 2021 | $528M | +397.7% | $232M | $3.21 | 127.7% | 56.1% |
| 2020 | $106M | +393.7% | $143M | $0.66 | 27.3% | 36.7% |
| 2019 | $22M | +107.6% | $120M | $-0.10 | 5.0% | 28.0% |
| 2018 | -$282M | -141.5% | -$239M | $-1.85 | -81.5% | -68.9% |
| 2017 | -$117M | -43.1% | -$77M | $-0.78 | -39.2% | -25.9% |
| 2016 | -$82M | +42.7% | -$52M | $-0.56 | -29.8% | -18.9% |
See IRWD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRWD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRWD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRWD — Frequently Asked Questions
Quick answers to the most common questions about buying IRWD stock.
Is IRWD growing earnings?
IRWD TTM EPS: $0.91. Net income: $151M. Earnings growth: N/A.
What are IRWD's profit margins?
Ironwood Pharmaceuticals, Inc. net margin is +8.1%, with operating margin at +40.1%. Margins sit within typical range for the sector.
How consistent are IRWD's earnings?
IRWD earnings data spans 2007-2025. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.